Mathilde M W Wille1, Laura H Thomsen2, Jens Petersen3, Marleen de Bruijne3,4, Asger Dirksen5, Jesper H Pedersen6, Saher B Shaker5. 1. Department of Respiratory Medicine, Gentofte Hospital, Kildegårdsvej 28, opg. 1D, st.th, DK-2900, Hellerup, Denmark. mathilde.winkler@gmail.com. 2. Department of Respiratory Medicine, Hvidovre Hospital, Kettegård Alle 30, DK-2650, Hvidovre, Denmark. 3. Department of Computer Science, DIKU, University of Copenhagen, Universitetsparken 5, DK-2100, København Ø, Denmark. 4. Biomedical Imaging Group Rotterdam, Departments of Radiology and Medical Informatics, Erasmus MC -University Medical Center Rotterdam, Rotterdam, The Netherlands. 5. Department of Respiratory Medicine, Gentofte Hospital, Kildegårdsvej 28, opg. 1D, st.th, DK-2900, Hellerup, Denmark. 6. Department of Thoracic Surgery, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100, København Ø, Denmark.
Abstract
OBJECTIVES: Screening for lung cancer should be limited to a high-risk-population, and abnormalities in low-dose computed tomography (CT) screening images may be relevant for predicting the risk of lung cancer. Our aims were to compare the occurrence of visually detected emphysema and interstitial abnormalities in subjects with and without lung cancer in a screening population of smokers. METHODS: Low-dose chest CT examinations (baseline and latest possible) of 1990 participants from The Danish Lung Cancer Screening Trial were independently evaluated by two observers who scored emphysema and interstitial abnormalities. Emphysema (lung density) was also measured quantitatively. RESULTS: Emphysema was seen more frequently and its extent was greater among participants with lung cancer on baseline (odds ratio (OR), 1.8, p = 0.017 and p = 0.002) and late examinations (OR 2.6, p < 0.001 and p < 0.001). No significant difference was found using quantitative measurements. Interstitial abnormalities were more common findings among participants with lung cancer (OR 5.1, p < 0.001 and OR 4.5, p < 0.001).There was no association between presence of emphysema and presence of interstitial abnormalities (OR 0.75, p = 0.499). CONCLUSIONS: Even early signs of emphysema and interstitial abnormalities are associated with lung cancer. Quantitative measurements of emphysema-regardless of type-do not show the same association. KEY POINTS: • Visually detected emphysema on CT is more frequent in individuals who develop lung cancer. • Emphysema grading is higher in those who develop lung cancer. • Interstitial abnormalities, including discrete changes, are associated with lung cancer. • Quantitative lung density measurements are not useful in lung cancer risk prediction. • Early CT signs of emphysema and interstitial abnormalities can predict future risk.
OBJECTIVES: Screening for lung cancer should be limited to a high-risk-population, and abnormalities in low-dose computed tomography (CT) screening images may be relevant for predicting the risk of lung cancer. Our aims were to compare the occurrence of visually detected emphysema and interstitial abnormalities in subjects with and without lung cancer in a screening population of smokers. METHODS: Low-dose chest CT examinations (baseline and latest possible) of 1990 participants from The Danish Lung Cancer Screening Trial were independently evaluated by two observers who scored emphysema and interstitial abnormalities. Emphysema (lung density) was also measured quantitatively. RESULTS:Emphysema was seen more frequently and its extent was greater among participants with lung cancer on baseline (odds ratio (OR), 1.8, p = 0.017 and p = 0.002) and late examinations (OR 2.6, p < 0.001 and p < 0.001). No significant difference was found using quantitative measurements. Interstitial abnormalities were more common findings among participants with lung cancer (OR 5.1, p < 0.001 and OR 4.5, p < 0.001).There was no association between presence of emphysema and presence of interstitial abnormalities (OR 0.75, p = 0.499). CONCLUSIONS: Even early signs of emphysema and interstitial abnormalities are associated with lung cancer. Quantitative measurements of emphysema-regardless of type-do not show the same association. KEY POINTS: • Visually detected emphysema on CT is more frequent in individuals who develop lung cancer. • Emphysema grading is higher in those who develop lung cancer. • Interstitial abnormalities, including discrete changes, are associated with lung cancer. • Quantitative lung density measurements are not useful in lung cancer risk prediction. • Early CT signs of emphysema and interstitial abnormalities can predict future risk.
Entities:
Keywords:
Comorbidity; Computed tomography; Emphysema; Interstitial abnormalities; Lung cancer
Authors: David S Gierada; Preethi Guniganti; Blake J Newman; Mark T Dransfield; Paul A Kvale; David A Lynch; Thomas K Pilgram Journal: Radiology Date: 2011-09-07 Impact factor: 11.105
Authors: Juan P de Torres; Gorka Bastarrika; Juan P Wisnivesky; Ana B Alcaide; Arantza Campo; Luis M Seijo; Jesús C Pueyo; Alberto Villanueva; María D Lozano; Usua Montes; Luis Montuenga; Javier J Zulueta Journal: Chest Date: 2007-12 Impact factor: 9.410
Authors: Anil K Chaturvedi; Hormuzd A Katki; Stephanie A Kovalchik; Martin Tammemagi; Christine D Berg; Neil E Caporaso; Tom L Riley; Mary Korch; Gerard A Silvestri Journal: N Engl J Med Date: 2013-07-18 Impact factor: 91.245
Authors: N Sakai; H Yabuuchi; M Kondo; Y Matsuo; T Kamitani; M Nagao; M Jinnouchi; M Yonezawa; T Kojima; Y Yano; H Honda Journal: Br J Radiol Date: 2015-07-08 Impact factor: 3.039
Authors: William H Amundson; Eric J Swanson; Ashley Petersen; Brian J Bell; Charles Hatt; Chris H Wendt Journal: J Thorac Imaging Date: 2020-03 Impact factor: 3.000
Authors: Johanna M Uthoff; Sarah L Mott; Jared Larson; Christine M Neslund-Dudas; Ann G Schwartz; Jessica C Sieren Journal: Chronic Obstr Pulm Dis Date: 2022-04-29